NASDAQ:STAA - STAAR Surgical Stock Price, News, & Analysis

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings results on Wednesday, August, 1st. The medical instruments supplier reported $0.09 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.01 by $0.08. The medical instruments supplier had revenue of $33.91 million for the quarter, compared to the consensus estimate of $27.10 million. STAAR Surgical had a return on equity of 16.04% and a net margin of 3.15%. View STAAR Surgical's Earnings History.

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Wednesday, November, 14th 2018. View Earnings Estimates for STAAR Surgical.

4 equities research analysts have issued twelve-month target prices for STAAR Surgical's stock. Their forecasts range from $21.00 to $55.00. On average, they expect STAAR Surgical's stock price to reach $40.3333 in the next twelve months. This suggests that the stock has a possible downside of 15.9%. View Analyst Price Targets for STAAR Surgical.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STAAR Surgical.

STAAR Surgical saw a increase in short interest in August. As of August 31st, there was short interest totalling 1,173,056 shares, an increase of 36.8% from the August 15th total of 857,551 shares. Based on an average daily volume of 435,777 shares, the short-interest ratio is currently 2.7 days. Currently, 2.8% of the company's stock are sold short. View STAAR Surgical's Current Options Chain.

Some companies that are related to STAAR Surgical include Qiagen (QGEN), Beigene (BGNE), Sartorius AG Preference Shares (SRT3), DENTSPLY SIRONA (XRAY), Bausch Health Companies (BHC), Valeant Pharmaceuticals (VRX), AveXis (AVXS), SWEDISH ORPHAN/S (SWTUY), Icon (ICLR), SONIC HEALTHCAR/S (SKHHY), Encompass Health (EHC), Recordati (RCDTF), Valeant Pharmaceuticals Intl (VRX), Sonic Healthcare (SKHCF) and bluebird bio (BLUE).

News headlines about STAA stock have been trending somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. STAAR Surgical earned a coverage optimism score of 0.18 on Accern's scale. They also gave media headlines about the medical instruments supplier an impact score of 46.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future. View Recent Headlines for STAAR Surgical.

STAAR Surgical's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.79%), Putnam Investments LLC (5.96%), Baillie Gifford & Co. (2.78%), Renaissance Technologies LLC (1.48%), Millennium Management LLC (1.40%) and Northern Trust Corp (1.13%). Company insiders that own STAAR Surgical stock include Caren L Mason, Deborah J Andrews, Hans-Martin Blickensdoerfer, Keith Holliday, Samuel J Gesten and William P Wall. View Institutional Ownership Trends for STAAR Surgical.

STAA stock was sold by a variety of institutional investors in the last quarter, including Putnam Investments LLC, Cortina Asset Management LLC, Rice Hall James & Associates LLC, Quantum Capital Management, Grandeur Peak Global Advisors LLC, King Luther Capital Management Corp, Bank of America Corp DE and Voya Investment Management LLC. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Keith Holliday, Samuel J Gesten and William P Wall. View Insider Buying and Selling for STAAR Surgical.

STAA stock was acquired by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Millennium Management LLC, Renaissance Technologies LLC, Acadian Asset Management LLC, BNP Paribas Arbitrage SA, ClariVest Asset Management LLC, EAM Investors LLC and BlackRock Inc.. View Insider Buying and Selling for STAAR Surgical.

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of STAA stock can currently be purchased for approximately $47.95.

STAAR Surgical has a market capitalization of $2.20 billion and generates $90.61 million in revenue each year. The medical instruments supplier earns $-2,130,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. STAAR Surgical employs 353 workers across the globe.

STAAR Surgical's mailing address is 1911 WALKER AVENUE, MONROVIA CA, 91016. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]